Top compounds associated with response to S100A4


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.089 0.02
mRNA nakiterpiosin CTRPv2 pan-cancer AAC -0.078 0.02
mRNA Bleomycin GDSC1000 pan-cancer AAC 0.084 0.02
mRNA tivozanib CTRPv2 pan-cancer AAC 0.085 0.02
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.02
mRNA AZD7762 CTRPv2 pan-cancer AAC 0.076 0.02
mRNA cediranib CTRPv2 pan-cancer AAC 0.13 0.02
mRNA Tipifarnib GDSC1000 pan-cancer AAC 0.081 0.02
mRNA Bryostatin 1 GDSC1000 pan-cancer AAC 0.08 0.02
mRNA CID-5951923 CTRPv2 pan-cancer AAC 0.088 0.02
Download CSV